The family of human papilloma viruses (HPV) comprises more than 100 genotypes.
Approximately 30 of the genotypes are responsible for infections in the human anogenital …

Introduction There is a need for state-of-the-art information in the area of sexually transmitted
infections (STIs) in relation to sexual function. There are an estimated 60 million people …

Imiquimod (IQ) is an immune-response modifying agent, first approved by FDA for the topical
treatment of external genital and perianal warts in 1997. It induces, through stimulation of …

Podophyllotoxin (PPT) is an antimitotic drug used topically in the treatment of anogenital
warts. Due to its toxicity it cannot be administered systemically as an anticancer agent …

Aim To evaluate the synergistic effect of Podophyllin as a chemotherapeutic adjunct to an
ablative therapy of liquid nitrogen cryotherapy versus liquid nitrogen cryotherapy alone in …

Human papillomavirus (HPV) infection is related to frequent cases of cervical cancer and
genital condyloma in humans. Up to now, numerous methods have come into existence for …

External genital warts, caused by human papillomavirus, have a significant clinical,
epidemiological, and financial impact, including the risk for malignant transformation …

External genital warts (EGWs) are a common sexually transmitted infection caused by the
human papillomavirus (HPV). Although over 100 HPV types have been identified, some of …

Importance of the field: Topical pharmacotherapy is an approach to consider in selected skin
cancers. Noninvasive, tissue-sparing, topical, self-administered treatments represent a …

External genital warts (EGW) are a sexually transmitted infection caused by various strains
of human papillomavirus (HPV). Several studies have described the direct and indirect costs …